PCRI's CEO Alex Scholz asks medical oncologist, Dr. Mark Scholz, about the basics of chemotherapy for prostate cancer. How do these agents work? What are the side effects? And in what order should they be used?
0:08 What is chemotherapy and how does it work in prostate cancer patients?
1:42 How do the side effects of carboplatin (trade name: Paraplatin) compare to Jevtana (cabazitaxel) and Taxotere (docetaxel)?
2:39 How does sequencing with these chemotherapy agents work? Meaning, in what order should they be used?
Don’t know your stage? Take the quiz: Visit [ Ссылка ]
To learn more about prostate cancer visit [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #Prostate #MarkScholzMD
